Insulin Analogues

Insulin analogues are modified variants of insulin which overcome these short comings and create physiological insulin profiles, leading to smoother glycemic control. Insulin analogues include

• Basal insulins

• Detemir

• glargine

• Rapid-acting analogues

• Aspart

• lispro

• Premixed combinations

• Protaminated aspart 30:70

• protaminated lispro 25:75; 50:50

Insulin analogues are indicated in a variety of situations. This paper will review the special situation in which analogues are being used, and focus on the premixed analogues as a means of achieving safe and simple control in the vast majority of patients.

Indications For Analogues

Situations with uncertainty in lifestyle/meals:

2. Situations with high/unpredictable fasting blood glucose:

Situations with high PP blood glucose, low pre-meal BG, poor HbA1c (in spite of ‘good’ glucose values)

Situations with ‘critical’ patients/ requiring immediate management

Analogues In School Children

Unique problems that school children with diabetes face are :

• Uncertain moods /meal quantity.

• Long breakfast- lunch gap.

• Midday meal at school, without insulin.

• Risk of hypoglycemia in school.

• Unplanned exercise/ physical activity.

• Unplanned snacks.

A 12 week long single – centre, prospective, randomized, open-label study at Bharti Hospital, Karnal, India, compared premixed aspart before breakfast & before dinner and regular aspart before lunch, vs. conventional four dose bolus- basal regime in school children with type 1 diabetes. There was 29 children in aspart group and 23 in conventional group (3 drop outs). Baseline age, duration of diabetes and HbA1c were similar.

Self reported concordance was higher with aspart regime (3/29 missed ≥ 1 injection in preceding 1 week) than the conventional regime (6/20). Mild hypoglycemia was less in aspart regime (0.66 episodes/pt./week). than conventional regime (2.59 episodes/pt./week). Fasting glucose was similar and postprandial glycemic control was markedly better in the premixed aspart group as compared to the conventional group .HbA1c improvement (-2.88 vs -2.05%).

Choice Of An Insulin Regime

Not all insulins are alike, and neither are all insulin regimes the same.

Choosing the correct regime is important, as a wrong choice may lead to hypoglycemia or poor control.

A wrong choice can also make the patient discontinue therapy. (and the doctor as well !)

Diabetes is a dynamic disease, and the treating physician may need to change the regime as per the requirements of the illness.

One may have to upgrade the regime (increase the number of units &/or the number of doses) if control is not achieved, or the comorbid conditions worsen.

Similarly, the doctor may want to downgrade therapy (decrease the number of units &/or the number of doses) if good control is achieved, co morbid illness resolves, or the patient is unwilling for intensive treatment.

Classification Of Insulin Regimes

Traditionally, insulin regimes have been classified as:-

• Basal

• Pre-mixed

• Intensive

With the availability of pre-mixed analogues, it has become simpler to start and intensity insulin therapy. A simpler classification that is proposed for insulin regimes is :-

• One – dose

• Two – dose

• Three – dose

This classification covers the multiple ways in which premixed analogues can be utilized.

Advantages Of Premixed Analogues

Premixed analogues, usually administered as 30:70 mixtures, are efficient in

• Achieving glycemic control

• Fasting glycemia

• Post prandial glycemia

• Hb A1c

• Reducing hypoglycemia

• Total

• Nocturnal

• Major events

These 30:70 mixtures are able to achieve successful therapeutic outcome because of the simplicity of use by both physician and patient .

One can begin with a single – dose insulin analogue regime, which will achieve adequate HbA1c in 45% cases. In the rest, upgrading or intensifying will achieve control in a total of 75% patients. A further intensification to three –dose regime will bring down HbA1c to target in a total of 87-90% , patients.

Using the same insulin to initiate, titrate, intensify and control diabetes is beneficial because it becomes easier for all members of the health care team – the nurses, diabetes educators, chemists, physician assistants – not to mention the patients and doctors, to use.

In a setting such as northern India, where trained manpower is scarce, many patients are illiterate, and chemists located in far- flung areas find it difficult to stock multiple brands of insulins, using a single analogue in multiple regimes makes sense.

Lack of monitoring facilities for frequent blood glucose estimation and inability of most patients to carry out SMBG , means that a ‘safe’ insulin, i.e., one which causes less hypoglycemia, and therefore needs less monitoring, should be chosen. Premixed analogues fill this need as well.

Conclusion

Premixed insulin analogues are simple , easy and effective method to use for glycemic control.

The use of premixed insulin analogues is appropriate for our clinical setting.